This page is part of the FHIR Specification (v4.4.0: R5 Preview #2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Device, Encounter, Patient, Practitioner, RelatedPerson |
Raw XML (canonical form + also see XML Format Specification)
Dosage with a Pre-Condition - Alprazolam (id = "medadmin0311")
<?xml version="1.0" encoding="UTF-8"?> <MedicationAdministration xmlns="http://hl7.org/fhir"> <id value="medadmin0311"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative with Details</b> </p> <p> <b> id</b> : medadmin0311</p> <p> <b> contained</b> : </p> <p> <b> status</b> : completed</p> <p> <b> medication</b> : </p> <p> <b> subject</b> : <a> Donald Duck</a> </p> <p> <b> occurence</b> : 16/01/2015 8:03:00 AM --> 16/01/2015 12:03:00 PM</p> <h3> Performers</h3> <table> <tr> <td> -</td> <td> <b> Actor</b> </td> </tr> <tr> <td> *</td> <td> <a> Patrick Pump</a> </td> </tr> </table> <p> <b> reason</b> : </p> <p> <b> request</b> : <a> MedicationRequest/medrx0305</a> </p> <h3> Dosages</h3> <table> <tr> <td> -</td> <td> <b> Text</b> </td> <td> <b> Route</b> </td> <td> <b> Dose</b> </td> </tr> <tr> <td> *</td> <td> 0.25mg PO every 6-12 hours as needed for menses from Jan 15-20, 2015. Do not exceed more than 4mg per day</td> <td> Oral Route <span> (Details : {SNOMED CT code '26643006' = 'Oral route', given as 'Oral Route'})</span> </td> <td> 1 TAB<span> (Details: http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm code TAB = 'Tablet')</span> </td> </tr> </table> </div> </text> <contained> <Medication> <id value="med0304"/> <code> <coding> <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/> <code value="308047"/> <display value="Alprazolam 0.25mg Oral Tablet"/> </coding> </code> </Medication> </contained> <status value="completed"/> <medication> <reference> <reference value="#med0304"/> </reference> </medication> <subject> <reference value="Patient/pat1"/> <display value="Donald Duck"/> </subject> <occurencePeriod> <start value="2015-01-15T22:03:00+01:00"/> <end value="2015-01-16T02:03:00+01:00"/> </occurencePeriod> <performer> <actor> <reference value="Practitioner/f007"/> <display value="Patrick Pump"/> </actor> </performer> <reason> <concept> <coding> <system value="http://snomed.info/sct"/> <code value="266599000"/> <display value="Dysmenorrhea"/> </coding> </concept> </reason> <request> <reference value="MedicationRequest/medrx0305"/> </request> <dosage> <text value="0.25mg PO every 6-12 hours as needed for menses from Jan 15-20, 2015. Do not exceed more than 4mg per day"/> <route> <coding> <system value="http://snomed.info/sct"/> <code value="26643006"/> <display value="Oral Route"/> </coding> </route> <dose> <value value="1"/> <unit value="TAB"/> <system value="http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm"/> <code value="TAB"/> </dose> </dosage> </MedicationAdministration>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.